We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 204

McRO, Inc. v. Bandai Namco Games America, No. 2015-1080 (Fed. Cir. Sept. 13, 2016)
  • Winston & Strawn LLP
  • USA
  • October 21 2016

Method claims reciting specific means or improvements to the art are patentable, while method claims directed to abstract results or effects using


Aventis Pharma S.A. & Sanofi-Aventis U.S., LLC v. Hospira, Inc. et al., Nos. 07-CV-0721 & 08-CV-0496 (Fed. Cir. April 9, 2012)
  • Winston & Strawn LLP
  • USA
  • April 11 2012

Inequitable conduct finding affirmed on the merits after Therasense, and claim construction and obviousness rulings upheld where appellant's proposed construction required imposing limitations not required by the claims or other intrinsic evidence


3M Co. v. Avery Dennison Corp., No. 2011-1339 (Fed. Cir. Mar. 26, 2012)
  • Winston & Strawn LLP
  • USA
  • April 11 2012

The patentee’s identification of products that “may infringe” its patent, suggestion that licenses are available, and indication that it will provide claim charts may create a justiciable controversy sufficient to establish declaratory judgment jurisdiction


Regents of the University of Minnesota v. ADA Medical Corp., No. 2012-1167 (Fed. Cir. June 3, 2013).
  • Winston & Strawn LLP
  • USA
  • June 14 2013

An earlier prosecution disclaimer applies to a later application so long as the two have the same or closely related claim limitation language


Dey, L.P. et al. v. Sunovion Pharm., Inc., No. 2012-1428 (Fed. Cir. May 20, 2013).
  • Winston & Strawn LLP
  • USA
  • May 30 2013

Clinical drug trials operating under standard confidentiality procedures do not constitute a third-party public use under pre-America Invents Act


SkinMedica, Inc. v. Histrogen Inc., No. 2012-1560 (Fed. Cir. Aug. 23, 2013)
  • Winston & Strawn LLP
  • USA
  • September 4 2013

Patent prosecution history and specification were held to implicitly redefine the terms of a claim


University of Utah v. Max-Planck-Gesellschaft Zur Forderung der Wissenschaften E.V., Case No. 2012-1540, -1541, -1661 (Fed. Cir. Aug. 19, 2013)
  • Winston & Strawn LLP
  • USA
  • September 4 2013

The Supreme Court does not have original jurisdiction over a suit to correct inventorship between a State University and officials from another State


The Ohio Willow Wood Co. v. Alps South, LLC, Nos. 2012-1642, 2013-1024 (Fed. Cir. Nov. 15, 2013)
  • Winston & Strawn LLP
  • USA
  • November 20 2013

In an equitable conduct assertion, an argument of lack of corroboration of testimony for invalidation of a patent is evaluated for materiality under


Accent Packaging, Inc. v. Leggett & Platt, Inc
  • Winston & Strawn LLP
  • USA
  • February 15 2013

A claim construction must not exclude the preferred embodiments, the possibility of altering an accused device to meet claim limitations does not


Motiva, LLC v. Int’l Trade Comm’n, No. 2012-1252 (Fed. Cir. May 13, 2013).
  • Winston & Strawn LLP
  • USA
  • May 24 2013

In an ITC proceeding, previous litigation of a patent by the complainant does not constitute a substantial investment in licensing to satisfy the